CD44 and neoplasm: This enhancement was attributed to the specific binding of the hybrid platelet membrane protein CD62p to the CD44 receptor, which is overexpressed on tumor cell surfaces.[59, 60] These findings suggest that the CD62p/CD44 interactions effectively mediate the active targeting of PGFP to the tumor microenvironment.